The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Are The Forecasted Market Size Figures For The Next Generation Tissue Biomarkers Market In 2026 And 2030?
The next generation tissue biomarkers market has experienced rapid growth in its size over the past few years. It is projected to expand from $3.03 billion in 2025 to $3.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.9%. Historically, this expansion has been driven by factors such as the dependence on traditional histopathology techniques, constrained biomarker identification approaches, rising oncology research, wider acceptance of companion diagnostics, and initial investments in genomic and proteomic studies.
The next generation tissue biomarkers market is anticipated to expand significantly in the near future. It will grow to $5.51 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. This projected growth during the forecast period is propelled by developments in next-generation sequencing technologies, the integration of AI-based tissue analysis, the broadening of spatial biology platforms, increasing financial commitment to multi-omics research, and enhanced collaborations between pharmaceutical firms and academic bodies. Significant trends anticipated for the forecast timeframe encompass the wider application of spatial biology and multi-omics methodologies, increased uptake of digital pathology and AI analysis in diagnostic procedures, an escalating demand for biomarkers in cancer treatment and companion diagnostics, advancements in drug discovery and development leveraging tissue biomarkers, and the integration of transcriptomic and metabolomic biomarkers to enable precision medicine.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27363&type=smp
Which Core Factors Are Supporting The Expansion Of The Next Generation Tissue Biomarkers Market?
The increasing need for personalized medicine is anticipated to fuel the expansion of the next generation tissue biomarkers market. Personalized medicine involves customizing treatments for individuals based on their genetic composition, lifestyle, and environmental elements. Its uptake is expanding due to ongoing progress in genomic technologies, enabling very specific and tailored treatment plans. This heightened demand for personalized medicine encourages the advancement of next-generation tissue biomarkers, as they supply the precise, individual-specific data necessary to customize treatments for each patient’s distinct tissue profile. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized treatments for rare disease patients, a rise from 6 in 2022. Among the personalized treatments approved in 2023 were also seven cancer drugs and three for other diseases and conditions. Consequently, the escalating demand for personalized medicine is propelling the growth of the next generation tissue biomarkers market.
How Does Segment Analysis Break Down The Next Generation Tissue Biomarkers Market Structure?
The next generation tissue biomarkers market covered in this report is segmented –
1) By Type: Genomic Biomarkers, Proteomic Biomarkers, Epigenetic Biomarkers, Transcriptomic Biomarkers, Metabolomic Biomarkers
2) By Technology: Immunohistochemistry, Next-Generation Sequencing, Mass Spectrometry (Ms)-Based Proteomics, Spatial Biology Platforms, Digital Pathology And Artificial Intelligence Analysis, Other Technologies
3) By Application: Oncology, Companion Diagnostics, Drug Discovery And Development, Neurology, Other Applications
4) By End Use: Hospitals And Reference Labs, Pharma And Biotech Companies, Academic And Research Institutes, Contract Research Organizations
Subsegments:
1) By Genomic Biomarkers: Single Nucleotide Polymorphisms, Copy Number Variations, Gene Fusions
2) By Proteomic Biomarkers: Protein Expression Levels, Post-Translational Modifications, Protein-Protein Interactions
3) By Epigenetic Biomarkers: Histone Modification Patterns, Chromatin Remodeling Biomarkers, Non-Coding Ribonucleic Acid Regulation
4) By Transcriptomic Biomarkers: Long Non-Coding Ribonucleic Acids, Circular Ribonucleic Acids, Alternative Splicing Variants
5) By Metabolomic Biomarkers: Lipid Profiles, Amino Acid Signatures, Organic Acids
What Trends Are Influencing The Next Generation Tissue Biomarkers Market?
Leading companies active in the next generation tissue biomarkers market are prioritizing the development of advanced solutions, such as genomic-based diagnostic assays and sequencing solutions, with the goal of improving the accuracy, speed, and personalization of cancer diagnosis and treatment. Genomic-based diagnostic assays and sequencing solutions are tools and techniques designed to examine genetic information to identify disease-related biomarkers, thereby enabling more precise and individualized approaches to diagnosis and therapy. For example, in August 2024, Illumina Inc., a US-based biotechnology company, obtained FDA approval for its TruSight Oncology Comprehensive test, along with two companion diagnostics, to efficiently connect cancer patients with targeted therapies. The test analyzes over 500 genes from a single tissue sample, facilitating accurate treatment selection for various solid tumors. It also automates biomarker detection and supports 24/7 deployment, substantially decreasing turnaround times and enhancing clinical efficiency, representing a contemporary strategy to streamline cancer diagnostics within a regulated framework.
Who Are The Companies Shaping The Next Generation Tissue Biomarkers Market Landscape?
Major companies operating in the next generation tissue biomarkers market are Roche Diagnostics, Thermo Fisher Scientific Inc., LabCorp., Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Myriad Genetics Inc., NeoGenomics Laboratories Inc., Foundation Medicine Inc., NanoString Technologies Inc., PathAI Inc., Biocartis Group NV, Personalis Inc., Ultivue Inc., Indica Labs Inc., Strata Oncology Inc., Genialis Inc., Alida Biosciences Inc., Biofidelity Ltd.
Access The Complete Next Generation Tissue Biomarkers Market Report:
Which Area Represents The Largest Portion Of The Next Generation Tissue Biomarkers Market?
North America was the largest region in the next generation tissue biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation tissue biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Next Generation Tissue Biomarkers Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=27363&type=smp
Browse Through More Reports Similar to the Global Next Generation Tissue Biomarkers Market 2026, By The Business Research Company
Nail Care Products Market Report 2026
https://www.thebusinessresearchcompany.com/report/nail-care-products-global-market-report
Nail Salon Market Report 2026
https://www.thebusinessresearchcompany.com/report/nail-salon-global-market-report
Nail Polish Market Report 2026
https://www.thebusinessresearchcompany.com/report/nail-polish-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model